These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 6291815
1. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension. Vecsei P, Abdelhamid S, Haack D, Lichtwald K, Lewicka S, von Mittelstädt G. Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815 [Abstract] [Full Text] [Related]
2. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N. J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240 [Abstract] [Full Text] [Related]
3. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas. Kigoshi T, Imaizumi N, Azukizawa S, Yamamoto I, Hosojima H, Uchida K, Morimoto S. Horm Res; 1984 Feb; 19(4):224-31. PubMed ID: 6745843 [Abstract] [Full Text] [Related]
4. Adrenal tumor producing 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone and aldosterone. Toyoda Y, Mizukoshi M, Umemoto M, Kuchii M, Ueyama K, Tomimoto S, Baba A, Shima H, Nishio I, Masuyama Y. Intern Med; 1996 Feb; 35(2):123-8. PubMed ID: 8680100 [Abstract] [Full Text] [Related]
5. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. Kem DC, Tang K, Hanson CS, Brown RD, Painton R, Weinberger MH, Hollifield JW. J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794 [Abstract] [Full Text] [Related]
6. Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone. Morioka M, Sen Y, Inoue K, Fujita Y. J Urol; 1990 Sep; 144(3):731-2. PubMed ID: 2388339 [Abstract] [Full Text] [Related]
7. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor. Uchida K, Kigoshi T, Iwasaki R, Morimoto S. Jpn J Med; 1989 Sep; 28(4):446-51. PubMed ID: 2554039 [Abstract] [Full Text] [Related]
8. Comparative biosynthetic studies in a case of primary aldosteronism. Dahl V, Scattini CM, Lantos CP. J Steroid Biochem; 1976 Sep; 7(9):715-7. PubMed ID: 185466 [No Abstract] [Full Text] [Related]
9. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. Takeda Y, Lewicka S, Koch S, Bige K, Vecsei P, Abdelhamid S, Cojocaru M, Harnik M. J Steroid Biochem Mol Biol; 1990 Nov 30; 37(4):599-604. PubMed ID: 2278845 [Abstract] [Full Text] [Related]
10. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. Biglieri EG, Schambelan M. J Clin Endocrinol Metab; 1979 Jul 30; 49(1):87-91. PubMed ID: 447820 [Abstract] [Full Text] [Related]
11. Periodic hypokalaemic paralysis, adrenal adenoma, and normal colonic transport of sodium and potassium. Richards P, Jones MB, Peart WS. Gut; 1973 Jun 30; 14(6):478-84. PubMed ID: 4719216 [Abstract] [Full Text] [Related]
12. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension. Semple PF, Mason PA, Fraser R. Clin Endocrinol (Oxf); 1980 May 30; 12(5):473-81. PubMed ID: 7428185 [Abstract] [Full Text] [Related]
13. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism. Fraser R, Beretta-Piccoli C, Brown JJ, Cumming AM, Lever AF, Mason PA, Morton JJ, Robertson JI. Hypertension; 1981 May 30; 3(3 Pt 2):I87-92. PubMed ID: 7262982 [Abstract] [Full Text] [Related]
14. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland. Saito T, Ikoma A, Saito T, Tamemoto H, Suminaga Y, Yamada S, Kawakami M, Suzuki T, Sasano H, Ishikawa SE. Endocr J; 2007 Apr 30; 54(2):287-93. PubMed ID: 17379961 [Abstract] [Full Text] [Related]
15. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. Sowers JR, Beck FW. Acta Endocrinol (Copenh); 1983 Feb 30; 102(2):258-64. PubMed ID: 6338674 [Abstract] [Full Text] [Related]
16. Zona fasciculata origin of 18-hydroxycorticosterone in the chronically suppressed zona glomerulosa. Kater CE, Biglieri EG. J Clin Endocrinol Metab; 1982 Oct 30; 55(4):628-33. PubMed ID: 7107809 [No Abstract] [Full Text] [Related]
17. Suppression of adrenal mineralocorticoid production in prehypertensive young adult men. Guthrie GP, Kotchen TA, Kotchen JM. J Clin Endocrinol Metab; 1983 Jan 30; 56(1):87-92. PubMed ID: 6292257 [Abstract] [Full Text] [Related]
18. Aldosterone metabolites and possible aldosterone precursors in hypertension. Vecsei P, Abdelhamid S, Mittelstädt GV, Lichtwald K, Haack D, Lewicka S. J Steroid Biochem; 1983 Jul 30; 19(1A):345-51. PubMed ID: 6887870 [Abstract] [Full Text] [Related]
19. A rare case of ACTH-independent macronodular adrenal hyperplasia associated with aldosterone-producing adenoma. Hayakawa E, Yoshimoto T, Hiraishi K, Kato M, Izumiyama H, Sasano H, Hirata Y. Intern Med; 2011 Jul 30; 50(3):227-32. PubMed ID: 21297325 [Abstract] [Full Text] [Related]
20. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome. Kater CE, Biglieri EG, Brust N, Chang B, Hirai J. J Clin Endocrinol Metab; 1982 Aug 30; 55(2):295-302. PubMed ID: 7045152 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]